CTRI/2017/03/008050尚未招募2 期
An open labelled multicentric prospective clinical study to assess the effectiveness of Kumarabharana Rasa in recurrent upper respiratory tract infections with special reference to chronic tonsillitis in children
Sri Dharmasthala Manjunatheshwara College of Ayurveda and Hospital0 个研究点目标入组 200 人开始时间: 待定最近更新:
试验速览
- 阶段
- 2 期
- 状态
- 尚未招募
- 发起方
- 入组人数
- 200
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Children of both genders between 5-10 years of age, who were suffering from repeated attacks of tonsillitis (chronic) in past year. Those participants whose parents are ready to sign the consent form and allow their children to participate in the clinical trial will be included.
排除标准
- •Patients with acute tonsillitis, peritonsillar abscess, tonsillar cyst, tonsillolith or with any other systemic disorders. Also the patients who have taken systemic steroids and/or antibiotics in the past four weeks.
研究者
相似试验
招募中
4 期
A study to assess the safety and efficacy of fixed dose combination of Montelukast 10 mg plus Acebrophylline SR 200 mg tablet in patients having bronchial asthmaCTRI/2020/02/023237Sun Pharma Laboratories Limited
已完成
3 期
To evaluate safety and performance of CREDENCEâ?¢ BtK Sirolimus Eluting BioResorbable Peripheral Scaffold System in subjects with Critical Limb Ischemiafollowing Percutaneous Transluminal Angioplasty of below the knee arteries.CTRI/2016/11/007473Meril Life Sciences Pvt Ltd30
已完成
2 期
Clinical study on JPF-16 Capsules in Sexual Dysfunction in FemalesCTRI/2017/06/008791Chatarubhuj Pharmaceutical Co30
已完成
不适用
A clinical trial to test the safety and effectiveness of Neuralzhein in management of memory loss related to age.CTRI/2019/08/020711exxus Laboratories DBA OPUS PHARMA
招募中
1 期
A clinical study to assess how safe and effective it is for subjects with hepatocellular carcinoma (HCC) to receive radiation therapy with TheraSphere followed by immunotherapy (durvalumab and tremelimumab treatment)Hepatocellular CarcinomaMedDRA version: 21.1Level: LLTClassification code: 10049010Term: Carcinoma hepatocellular Class: 10029104CTIS2023-508945-41-00Biocompatibles UK Limited107